Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1562-2008

BD DifcoTM Neisseria Meningitidis Antiserum Group Y 241113, 1mL, in vials, which were labeled in part...

Lee Laboratories, Inc. / initiated 2007-09-06 / Terminated

BD Diagnostic Systems / Lee Laboratories began a recall of BD DifcoTM Neisseria Meningitidis Antiserum Group Y 241113, 1mL, in vials, which were labeled in part, 8019456 6250890 N. MEN. GP Y UNLABELED LYOPH, Becton... on . The reason FDA records is "Exhibits cross reactivity with Neisseria meningitides Group W135". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1562-2008
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Lee Laboratories, Inc.
Product
BD DifcoTM Neisseria Meningitidis Antiserum Group Y 241113, 1mL, in vials, which were labeled in part, 8019456 6250890 N. MEN. GP Y UNLABELED LYOPH, Becton, Dickinson and Company, Sparks, MD 21152. The product is packaged in 100 vial units For use in slide agglutination tests for serotyping Neisseria Meningitidis.
Product code
GTJ Antisera, All Groups, N. Meningitidis
Reason for recall
Exhibits cross reactivity with Neisseria meningitides Group W135
FDA root cause
Mixed-up of materials/components
Action
BD Diagnostics sent an Urgent Product Recall letter, dated September 2007, to all accounts, requesting the discontinue of distribution and that any remaining inventory of the recalled product be discarded. BD will issue credit or send replacement. A receipt of notification needs to be completed and sent back whether or not customers have any remaining inventory. Also, a customer list of end-users who were shipped this product needs to be provided so that the firm may inform them of the issue.
Quantity in commerce
200 units
Distribution
Worldwide Distribution --- including USA and country of New Zealand.
Product codes and lots
Lot #7136172, EXP 2009-09-19